Clinical Trials Logo
  1. Home
  2. Fibrillation, Atrial
  3. NCT04761315
  4. Details
NCT04761315 Clinical Trial

Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Fibrillation, Atrial Clinical Trial

Official title:
Detecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04761315
Other study ID # TFM 2016-18
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2015
Est. completion date December 31, 2016

Study information
Verified date February 2021
Source Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.

Description:

The presence of interatrial block (IAB) is associated with the development of atrial fibrillation (AF). The aim of this study was to determine whether P-wave duration and presence of IAB before the implantation of a cardiac implantable electronic device (CIED) are associated with the presence of atrial high rate episodes (AHRE), during long-term follow-up.

Recruitment information / eligibility
Status Completed
Enrollment 380
Est. completion date December 31, 2016
Est. primary completion date December 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Patients in sinus rhythm - with or without previous paroxysmal AF - with dual-chamber pacemakers (PMs), implantable cardioverterdefibrillators (ICDs), and devices for cardiac resynchronization therapy (CRT) - capable of atrial activity monitoring were included in the study Exclusion Criteria: -Previous documented atrial fibrillation

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Outcome
Type Measure Description Time frame Safety issue
Primary Atrial high rate new episodes New episodes of atrial high rate episodes 24 months
See also
  Status Clinical Trial Phase
Completed NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism Phase 2
Terminated NCT00437242 - Odiparcil QT Definitive Study Phase 1
Completed NCT00402363 - Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation Phase 3
Completed NCT00240643 - Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke Phase 2
Completed NCT00041496 - Prevention Of Recurrence Of Atrial Fibrillation Phase 2
Not yet recruiting NCT06200311 - Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men N/A
Withdrawn NCT03401931 - Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers
Completed NCT04537507 - Atrial Fibrillation and Non-obstructive Coronary Lesions
Completed NCT00911300 - Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm Phase 2